Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Director/PDMR Shareholding

23 Feb 2021 07:00

Marechale Capital Plc - Director/PDMR Shareholding

Marechale Capital Plc - Director/PDMR Shareholding

PR Newswire

London, February 22

23 February 2021

Marechale Capital plc

(“Marechale” or the “Company”)

Exercise of Options and Issue of Equity

Marechale Capital Plc (AIM: MAC) announces that it has received a notification from its Chief Executive, Patrick Booth-Clibborn, an option holder to exercise options over 2,232,125 ordinary shares in the Company at an exercise price of 1.12 pence per share for total proceeds of approximately £25,000.

Following Admission (defined below), Patrick Booth-Clibborn will hold a total of 12,076,865 ordinary shares, representing approximately 15.01 per cent. of the enlarged issued share capital of the Company. The Company has options outstanding over 7,066,076 ordinary shares in aggregate representing 8.78 per cent. of the Company’s issued share capital.

Admission to AIM

Application has been made for the new ordinary shares which are to be issued in respect of this exercise of options to be admitted to trading on AIM ("Admission"). It is expected that Admission of the new ordinary shares will become effective at 8.00 a.m. on or around 26 February 2021. The new ordinary shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after Admission and will otherwise rank on Admission pari passu in all respects with the existing ordinary shares.

Total Voting Rights

Following Admission, the total number of ordinary shares in issue will be 80,461,247. The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares with voting rights will be 80,461,247. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information please contact:

Marechale Capital plc Mark Warde-Norbury / Patrick Booth-ClibbornTel: +44 (0)20 7628 5582
Cairn Financial Advisers LLP (Nomad) Jo Turner / Sandy Jamieson / Mark RogersTel: +44 (0)20 7213 0880
Novum Securities Limited (Broker) Colin RowburyTel: +44 (0)20 7399 9427

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1Details of the person discharging managerial responsibilities/person closely associated
a.NamePatrick Booth-Clibborn
2Reason for notification
a.Position/StatusChief Executive
b.Initial notification/ AmendmentInitial
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.NameMarechale Capital plc
b.LEI213800WAVVOPS85N2205
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.Description of the financial instrument, type of instrument Identification CodeOrdinary Shares ISIN: GB0005401087
b.Nature of the transactionExercise of Options
c.Price(s) and volume(s)
Volume(s)Price (p)
a) 2,232,1251.12p
d.- Aggregated Volume- Price -2,232,125-1.12 pence per share
e.Date of the transaction22/02/2021
f.Place of the transactionLondon Stock Exchange, AIM
Date   Source Headline
9th Nov 20112:50 pmRNSHolding(s) in Company
22nd Sep 201111:20 amRNSResult of AGM
20th Sep 201110:03 amRNSDirector/PDMR Shareholding
25th Aug 20119:46 amRNSFinal Results
18th Apr 20111:44 pmRNSDirector/PDMR Shareholding
14th Apr 20112:16 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDirectorate Change
31st Mar 20113:28 pmRNSIssue of Equity
29th Mar 20113:17 pmRNSDirectorate Appointment & Dealing
28th Mar 20113:39 pmRNSDirector/PDMR Shareholding
16th Mar 20119:20 amRNSDirector/PDMR Shareholding
25th Feb 20113:46 pmRNSHolding(s) in Company
9th Feb 20112:02 pmRNSDirector/PDMR Shareholding
19th Jan 20111:34 pmRNSDirector/PDMR Shareholding
13th Jan 20114:19 pmRNSHolding(s) in Company
11th Jan 201112:27 pmRNSDirector/PDMR Shareholding
15th Dec 201012:00 pmRNSHalf Yearly Report
29th Sep 20103:06 pmRNSResult of AGM
22nd Sep 201010:34 amRNSDirector/PDMR Shareholding
7th Sep 201012:00 pmRNSFinal Results and Notice of General Meeting
17th Mar 20109:00 amRNSChange of Adviser
22nd Feb 20103:15 pmRNSResult of GM
12th Feb 201012:00 pmRNSDirector/PDMR Shareholding
4th Feb 201011:00 amRNSDirector/PDMR Shareholding
29th Jan 201012:00 pmRNSNotice of General Meeting
12th Jan 20107:00 amRNSApplication for New Ordinary Shares
23rd Dec 20092:31 pmRNSHalf Yearly Report
17th Dec 20095:15 pmRNSResult of AGM
7th Dec 200912:28 pmRNSHoldings in Company / Directors Dealings
23rd Nov 20097:00 amRNSAcquisition and AGM
23rd Oct 20099:17 amRNSHolding in Company
15th Oct 20092:41 pmRNSChange of Name of Nominated Adviser and Broker
30th Sep 20094:00 pmRNSAnnual Report & Accounts
18th Sep 20097:00 amRNSNotifiable Interests
18th Sep 20097:00 amRNSHolding in Company
28th Aug 20092:30 pmRNSAcquisition of Whim Gully Capital LLP
28th Aug 20092:30 pmRNSPreliminary Results and Notice of General Meeting
21st Jul 20097:00 amRNSDisposal
6th Aug 200810:59 amRNSDirector/PDMR Shareholding
23rd Jun 20087:00 amRNSAppointment of joint broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.